mk 0663 has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Kader, M; Taha, RI | 1 |
| Burgos Pratx, L; Camino, P; Coca Mogro, B; Salamone, H; Santoro, D; Scordo, W; Valiente, VL | 1 |
2 other study(ies) available for mk 0663 and Acute Kidney Failure
| Article | Year |
|---|---|
Comparative nephroprotective effects of curcumin and etoricoxib against cisplatin-induced acute kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Blood Urea Nitrogen; Cisplatin; Creatinine; Curcumin; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Gene Expression Regulation; Glutathione; Malondialdehyde; Oxidative Stress; Rats | 2020 |
Etoricoxib-induced immune hemolytic anemia: first case presenting acute kidney failure.
Topics: Acute Kidney Injury; Aged, 80 and over; Anemia, Hemolytic; Complement C3b; Complement C3d; Coombs Test; Etoricoxib; Female; Humans; Immunoglobulin G | 2019 |